David N. Chernoff


Dr. David Chernoff brings two decades of bio/pharma industry experience to his biomedical consulting practice, Chernoff Consulting, LLC, which focuses on translational medicine.  He currently consults with numerous bio/pharma companies in the United States, Canada and Europe.

Previously, he was Vice President of Corporate Technology at Elan Pharmaceuticals and Medical Director at Chiron Diagnostics, where he played a pivotal role in the development of viral load assays for HIV, HCV, HBV and CMV.  Dr. Chernoff spent two years as an Entrepreneur-in-Residence and one year as an Operating Partner at the venture firm, TPG, where he was actively involved in due diligence and incubating new companies.

Dr. Chernoff has served as the acting Chief Medical Officer of several startup biotech companies including Crescendo Bioscience, XDX, CardioDX, Tethys Biosciences and Adamas Pharmaceuticals.  He also served as CMO for Schiff Nutrition and Aquinox Pharma in Vancouver, BC.  He is currently serving as VP of Medical Affairs for Crescendo Bioscience and Adamas Pharma, both in the San Francisco Bay Area.


  • BS, Biology, Yale University
  • MD, New York University
  • Internship, Residency and Fellowship training at University of California, San Francisco Medical Center


  • Member, Buck Advisory Council, The Buck Institute for Research on Aging
  • Member, Board of Directors, Project Open Hand
  • AIDS Caregiver Award, AIDS Healthcare Foundation
  • Academic Achievement Awards
  • First Prize, Eastern Student Research Forum
  • President, Alpha Omega Alpha
  • New York University Honors Program
Change text size: